Moolec Science (MLECW) Other Non Operating Income (2022 - 2024)
Moolec Science (MLECW) posted Other Non Operating Income of $608520.0 for Q4 2024, down 15.2% sequentially from $717573.0 in Q3 2024, and up 594.44% YoY from $87627.2 in Q1 2024.
Moolec Science (MLECW) Other Non Operating Income (2022 - 2024) Analysis & Trends
Moolec Science has reported Other Non Operating Income for 3 years, with the latest figure at $608520.0 in Q4 2024.
- Quarterly Other Non Operating Income rose 594.44% year-over-year to $608520.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $2.8 million (up 54.8% YoY) and the FY2024 annual result came in at $1.9 million, up 81.36% from the prior year.
- Other Non Operating Income slipped to $608520.0 in Q4 2024 per MLECW's latest filing, from $717573.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $1.3 million in Q2 2023 and troughed at -$313384.0 in Q4 2022.
- A 3-year average of $423168.5 and a median of $436336.5 in 2023 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2023 and 2024: Other Non Operating Income surged 18134.07% in 2023, then slumped 75.28% in 2024.
- Over 3 years, Other Non Operating Income stood at -$313384.0 in 2022, then soared by 60.73% to -$123072.0 in 2023, then surged by 594.44% to $608520.0 in 2024.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $608520.0, $717573.0, and $311633.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 608,520.00 |
| Sep 30, 2024 | 717,573.00 |
| Jun 30, 2024 | 311,633.00 |
| Mar 31, 2024 | 1.13 Mn |
| Dec 31, 2023 | -123,072.00 |
| Sep 30, 2023 | 561,040.00 |
| Jun 30, 2023 | 1.26 Mn |
| Mar 31, 2023 | 86,120.00 |
| Dec 31, 2022 | -313,384.00 |
| Sep 30, 2022 | -3,111.00 |